Clinical Trial Update: Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating biased opioid agonists for managing opioid withdrawal in people with opioid use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Biased opioid agonist (investigational)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Use Disorder | Phase 2 | Status: COMPLETED